VitaNova Life Sciences (VNOV) EBIT (2017 - 2026)
VitaNova Life Sciences (VNOV) reported EBIT of $46731.0 for Q1 2026, down 57.08% on a YoY basis from $108874.0 in Q1 2025, and down 52.88% quarter-over-quarter from $99170.0 in Q4 2025.
VitaNova Life Sciences (VNOV) EBIT (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has reported EBIT for 10 years, with the latest figure at $46731.0 in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 57.08% year-over-year to $46731.0; the trailing twelve-month figure through Jan 2026 stood at $1.2 million (up 233.31% YoY), and the FY2025 full-year result was $1.2 million, up 487.62% from the prior year.
- EBIT for Q1 2026 stood at $46731.0, down from $99170.0 in the prior quarter.
- The five-year high for EBIT was $1.1 million in Q2 2025, with the low at -$45414.0 in Q3 2024.
- Historically, EBIT has averaged $90016.9 across 5 years, with a median of $2601.0 in 2022.
- Annual changes were most pronounced in 2023 — EBIT slumped 1236.22% — and 2024, when it surged 5406.34%.
- VitaNova Life Sciences' EBIT stood at $2601.0 in 2022, then plunged by 436.6% to -$8755.0 in 2023, then soared by 815.02% to $62600.0 in 2024, then jumped by 58.42% to $99170.0 in 2025, then plunged by 52.88% to $46731.0 in 2026.
- The last three EBIT figures came in at $46731.0 (Q1 2026), $99170.0 (Q4 2025), and -$32440.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.15 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.14 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 509.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 182.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 17.13 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -7.37 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -46,000.00 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -2.18 Mn |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | 46,731.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 46,731.00 |
| Oct 31, 2025 | 99,170.00 |
| Jul 31, 2025 | -32,440.00 |
| Apr 30, 2025 | 1.08 Mn |
| Jan 31, 2025 | 108,874.00 |
| Oct 31, 2024 | 62,600.00 |
| Jul 31, 2024 | -45,414.00 |
| Apr 30, 2024 | 232,683.00 |
| Jan 31, 2024 | 5,948.00 |
| Oct 31, 2023 | -8,755.00 |
| Jul 31, 2023 | -24,247.00 |
| Apr 30, 2023 | -4,385.00 |
| Jan 31, 2023 | -24,577.00 |
| Oct 31, 2022 | 2,601.00 |
| Jul 31, 2022 | 2,134.00 |
| Apr 30, 2022 | 1,937.00 |
| Jan 31, 2022 | 25,173.00 |
| Oct 31, 2021 | -29,991.00 |
| Jul 31, 2021 | -10,486.00 |
| Apr 30, 2021 | -7,196.00 |